• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Morrison Gregory E A

    11/24/23 1:20:13 PM ET
    $ARGO
    Specialty Insurers
    Finance
    Get the next $ARGO alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    MORRISON GREGORY E A

    (Last) (First) (Middle)
    90 PITTS BAY ROAD

    (Street)
    PEMBROKE D0 HM 08

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    11/16/2023
    3. Issuer Name and Ticker or Trading Symbol
    Argo Group International Holdings, Ltd. [ ARGO ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    No securities beneficially owned. Exhibit List: Ex.24 - Power of Attorney
    No securities are beneficially owned.
    /s/ Stacey Fay Weltman, as Attorney-in-Fact 11/24/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ARGO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ARGO

    DatePrice TargetRatingAnalyst
    3/13/2023$30.00Buy → Neutral
    Compass Point
    2/28/2023Mkt Perform → Underperform
    Raymond James
    9/12/2022$45.50 → $28.50Neutral → Buy
    Compass Point
    8/10/2022Outperform → Mkt Perform
    Raymond James
    8/9/2022$35.00Buy → Neutral
    Compass Point
    2/9/2022$70.00 → $60.00Strong Buy → Outperform
    Raymond James
    2/9/2022$47.50Buy → Neutral
    Compass Point
    11/4/2021$65.00 → $70.00Strong Buy
    Raymond James
    More analyst ratings

    $ARGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Morrison Gregory E A

      3 - Argo Group International Holdings, Ltd. (0001091748) (Issuer)

      11/24/23 1:20:13 PM ET
      $ARGO
      Specialty Insurers
      Finance
    • SEC Form 3 filed by new insider Mcconnie Gregory Noel

      3 - Argo Group International Holdings, Ltd. (0001091748) (Issuer)

      11/24/23 1:19:46 PM ET
      $ARGO
      Specialty Insurers
      Finance
    • SEC Form 3 filed by new insider Macloughlin Seamus Michael

      3 - Argo Group International Holdings, Ltd. (0001091748) (Issuer)

      11/24/23 1:18:59 PM ET
      $ARGO
      Specialty Insurers
      Finance

    $ARGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Argo Group downgraded by Compass Point with a new price target

      Compass Point downgraded Argo Group from Buy to Neutral and set a new price target of $30.00

      3/13/23 8:54:33 AM ET
      $ARGO
      Specialty Insurers
      Finance
    • Argo Group downgraded by Raymond James

      Raymond James downgraded Argo Group from Mkt Perform to Underperform

      2/28/23 6:18:41 AM ET
      $ARGO
      Specialty Insurers
      Finance
    • Argo Group upgraded by Compass Point with a new price target

      Compass Point upgraded Argo Group from Neutral to Buy and set a new price target of $28.50 from $45.50 previously

      9/12/22 9:01:43 AM ET
      $ARGO
      Specialty Insurers
      Finance